Huancahuire-Vega, S.; Ponce-Soto, L. A.; Martins-de-Souza, D.; Marangoni, S.: Structural and functional characterization of brazilitoxins II and III (BbTX-II and -III), two myotoxins from the venom of Bothrops brazili snake. Toxicon 54 (6), pp. 818 - 827 (2009)

Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J.; Horstmann, S.; Kloiber, S. et al.; Menke, A.; Bondy, B.; Rupprecht, R.; Domschke, K.; Baune, B. T.; Arolt, V.; Rush, A. J.; Holsboer, F.; Müller-Myhsok, B.: Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 73, pp. 665 - 666 (2009)

Jastorff, A. M.; Haegler, K.; Maccarrone, G.; Holsboer, F.; Weber, F.; Ziemssen, T.; Turck, C. W.: Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Proteomics Clinical Applications 3 (11), pp. 1273 - 1287 (2009)

Kopczak, A.; Kilimann, I.; von Rosen, F.; Schneider, H. J.; Stalla, G. K.; Schneider, M.: Different symptoms and results in the insulin tolerance test depending on the posture in patients with brain damage. Experimental and Clinical Endocrinology & Diabetes 117 (10), pp. 662 - 663 (2009)

Roemmler, J.; Steffin, B.; Gutt, B.; Schneider, H. J.; Sievers, C.; Bidlingmaier, M.; Schopohl, J.: The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. Experimental and Clinical Endocrinology & Diabetes 117 (10), p. 664 - 664 (2009)

Schüssler, P.; Kluge, M.; Dresler, M.; Yassouridis, A.; Steiger, A.: Sleep-impairing effect of intravenous corticotropin-releasing hormone on sleep EEG in young healthy women. Experimental and Clinical Endocrinology & Diabetes 117 (10), p. 664 - 664 (2009)

Shan, B.; Onofri, C.; Theodoropoulou, M.; Buchfelder, M.; Kreutzer, J.; Rachinger, W.; Losa, M.; Stalla, G. K.; Arzt, E.; Renner, U.: Expression, regulation and function of HIF-1 alpha and RSUME in murine and human pituitary tumor cells. Experimental and Clinical Endocrinology & Diabetes 117 (10), p. 657 - 657 (2009)

Sievers, C.; Dimopoulou, C.; Pfister, H.; Lieb, R.; Steffin, B.; Roemmler, J.; Schopohl, J.; Mueller, M.; Schneider, H. J.; Ising, M. et al.; Wittchen, H. U.; Stalla, G. K.: Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clinical Endocrinology 71 (5), pp. 691 - 701 (2009)

Sievers, C.; Klotsche, J.; Pieper, L.; Schneider, H. J.; Wittchen, H. U.; Stalla, G. K.; Mantzoros, C.: Testosterone levels in relation to cardiovascular risk factors and cardiovascular events in women; a cross-sectional and prospective cohort study in German primary care patients. Experimental and Clinical Endocrinology & Diabetes 117 (10), p. 659 - 659 (2009)

Theodoropoulou, M.; Bakkali, K. L.; Monteserin, J. L.; Errami, M.; Stalla, G. K.: CB1 cannabinoid receptor positively regulates pro-opiomelanocortin (POMC) transcription through activation of the cAMP-response element (CRE)-binding protein (CREB). Experimental and Clinical Endocrinology & Diabetes 117 (10), pp. 657 - 658 (2009)

Theodoropoulou, M.; Tichomirowa, M. A.; Sievers, C.; Yassouridis, A.; Arzberger, T.; Hougrand, O.; Deprez, M.; Daiy, A. F.; Petrossians, P.; Pagotto, U. et al.; Beckers, A.; Stalla, G. K.: Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly. International Journal of Cancer 125 (9), pp. 2122 - 2126 (2009)

Wittmann, D. M.; Blöchl, F.; Trümbach, D.; Wurst, W.; Prakash, N.; Theis, F. J.: Spatial Analysis of Expression Patterns Predicts Genetic Interactions at the Mid-Hindbrain Boundary. PLoS Computational Biology 5 (11), doi: 10.1371/journal.pcbi.1000569 (2009)

Roselli, F.; Pisciotta, N. M.; Perneczky, R.; Pennelli, M.; Aniello, M. S.; De Caro, M. F.; Ferrannini, E.; Tartaglione, B.; Defazio, G.; Rubini, G. et al.; Livrea, P.: Severity of Neuropsychiatric Symptoms and Dopamine Transporter Levels in Dementia with Lewy Bodies: A I-123-FP-CIT SPECT Study. Movement Disorders 24 (14), pp. 2097 - 2103 (2009)

Fenzl, T.; Flachskamm, C.; Rossbauer, M.; Deussing, J. M.; Kimura, M.: Circadian rhythms of basal orexin levels in the hypothalamus are not influenced by an impaired corticotropin-releasing hormone receptor type 1 system. Behavioural Brain Research 203 (1), pp. 143 - 145 (2009)

Bergen, S.; Chen, J. C.; Dagdang, E.; Foon, T. S.; Goes, F. S.; Houlihan, L. M.; Kloiber, S.; Kumar, R. A.; Kuzman, M. R.; Menke, A. et al.; Pedroso, I.; Videtic, A.; Villafuerte, S.; DeLisi, L. E.: Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11-15 October 2008. Psychiatric Genetics 19 (5), pp. 219 - 236 (2009)

Correa-de-Santana, E.; Fröhlich, B.; Labeur, M.; Paez-Pereda, M.; Theodoropoulou, M.; Monteserin, J. L.; Renner, U.; Stalla, G. K.: NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Journal of Endocrinology 203 (1), pp. 111 - 122 (2009)

Haseneder, R.; Kratzer, S.; Kochs, E.; Hofelmann, D.; Auberson, Y.; Eder, M.; Rammes, G.: The xenon-mediated antagonism against the NMDA receptor is non-selective for receptors containing either NR2A or NR2B subunits in the mouse amygdala. European Journal of Pharmacology 619 (1-3), pp. 33 - 37 (2009)

Horlemann, J.; Zieglgänsberger, W.; Kanitscheider, C.: INSOMNIA AMONGST PATIENTS WITH CHRONIC PAIN AND INFLUENCE OF ADJUSTMENT OF PAIN MEDICATION IN GERMANY. Value in Health 12 (7), p. A384 - A384 (2009)

Horstmann, S.; Binder, E. B.: Pharmacogenomics of antidepressant drugs. Pharmacology & Therapeutics 124 (1), pp. 57 - 73 (2009)

Jacob, W.; Yassouridis, A.; Marsicano, G.; Monory, K.; Lutz, B.; Wotjak, C. T.: Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain and Behavior 8 (7), pp. 685 - 698 (2009)